SINGAPORE (Oct 24): Singapore eDevelopment says its US biomedical subsidiary has developed a breakthrough low-calorie, low glycemic index, natural, modified sugar Laetose.

Global Biolife has established a collaboration with top US candy manufacturer, Quality Candy Company LLC, for the development, manufacture and global distribution of Laetose.

Developed by Daryl L. Thompson, Global BioLife’s director of scientific initiatives, Laetose is a functional sugar with a 30% to 50% lower calorie-count than regular sugar, possesses low glycemic properties, and also assists in mitigating inflammatory responses.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook